NO | ଉତ୍ପାଦଗୁଡିକ | CAS ନଂ | ପ୍ରୟୋଗ | ମୁଖ୍ୟ ଗୁଣବତ୍ତା ସୂଚକ | | ||||
ଶୁଦ୍ଧତା | ଇସୋମର | | ନିର୍ଦ୍ଦିଷ୍ଟ ଅଶୁଦ୍ଧତା | | * ସର୍ବାଧିକ 1 | ଆର୍ଦ୍ରତା | ||||
1 | Fmoc-Cys (Acm) -OH | | 86060-81-3 | ଡିସଲଫାଇଡ୍ ବଣ୍ଡ୍ | | ≥99.0% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
2 | Fmoc-Cys (Mmt) -OH | | 177582-21-7 | ଡିସଲଫାଇଡ୍ ବଣ୍ଡ୍ | | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
3 | Fmoc-Cys (4-allylbutyrate) -OH | | / | ଡିସଲଫାଇଡ୍ ବଣ୍ଡ୍ | | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
4 | Mpa (Trt) -OH | | 27144-18-9 | କ୍ରମର ସମାପ୍ତି | | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
5 | Fmoc-Thr (tBu) -OL | | 189337-28-8 | ଅକ୍ଟୋରେଟାଇଡ୍ | | ≥97.0% | ≤0.3% | ≤0.5% | ≤1.0% | ≤1.0% |
6 | Fmoc-D-Arg (pbf) -OH | | 187618-60-6 | ଡେସମୋପ୍ରେସିନ୍ | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤2.0% |
7 | Fmoc-Gly-Gly-OH | | 35665-38-4 | ବିଭାଲିରୁଦ୍ଦିନ | | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
8 | Fmoc-Gly-Gly-Gly-OH | | 170941-79-4 | ଟେରିଲିପ୍ରେସିନ୍ | | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
9 | Fmoc-Gly-Gly-Gly-Gly-OH | | / | ବିଭାଲିରୁଦ୍ଦିନ | | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
10 | Fmoc-Gly-Asp (tBu) -OH | | / | ବିଭାଲିରୁଦ୍ଦିନ | | ≥99.5% | / | ≤0.15% | ≤0.2% | ≤1.0% |
11 | Boc-Cys (Trt) -OH | | 21947-98-8 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
12 | Boc-Arg (pbf) -OH | | 200124-22-7 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
13 | Boc-Ala-OH | | 15761-38-3 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
14 | Boc-D-Phe-OH | | 18942-49-9 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
15 | Boc-Gly-OH | | 4530-20-5 | କ୍ରମର ସମାପ୍ତି | | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
16 | Boc-Lys (Boc) -OH.DCHA | | 15098-69-8 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
17 | Boc-Ser (tBu) -OH | | 7738-22-9 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
18 | Boc-Thr (tBu) -OH | | 13734-40-2 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
19 | Boc-D-Ala-OH | | 7764-95-6 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
20 | Boc-Met-OH | | 2488-15-5 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
21 | Boc-Tyr (tBu) -OH | | 47375-34-8 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
22 | Boc-D-Arg (pdf) -OH | | 187618-60-6 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
23 | Boc-Asp (OtBu) -OH.DCHA | | 1913/12/8 | କ୍ରମର ସମାପ୍ତି | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
24 | Fmoc-HomoArg (pbf) -OH | | 1159680-21-3 | ଏପଟିଫିବାଟାଇଡ୍ | | ≥98.5% | ≤0.2% | / | ≤0.5% | ≤2.0% |
25 | Fmoc-Asp-OtBu | | 129460-09-9 | ଥିମାଲଫାସିନ୍ | | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
26 | Fmoc-Tyr (Me) -OH | | 77128-72-4 | କାର୍ବେଟୋସିନ୍ | | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
27 | Fmoc-Orn (Boc) -OH | | 109425-55-0 | Atosiban ଓମନିପ୍ରେସିନ୍ | ଡାପ୍ଟୋମାଇସିନ୍ | | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤2.0% |
28 | Fmoc-D-Tyr (Et) -OH | | 162502-65-0 | Atosiban | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
29 | Fmoc-Asp (OAll) -OH | | 146982-24-3 | ମେଲାନୋଟାନ୍ | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
30 | Ac-Nle-OH | | 15891-49-3 | ମେଲାନୋଟାନ୍ | | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
31 | Fmoc-Nle-OH | | 77284-32-3 | ମେଲାନୋଟାନ୍ | Afamelanotide | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
32 | Ac-Glu (OtBu) -OH | | 84192-88-1 | Argireline ଆସେଟିଲ୍ ଅଷ୍ଟାପେପ୍ଟାଇଡ୍ -3 | | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
33 | Ac-β-Ala-OH · DCHA | | / | ଆସେଟିଲ୍ ଟେଟ୍ରାପେପ୍ଟାଇଡ୍ -5 | | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
34 | Fmoc-ß-Ala-OH | | 35737-10-1 | ଆସେଟିଲ୍ ଟେଟ୍ରାପେପ୍ଟାଇଡ୍ -5 | | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
35 | Fmoc-Hyp (tBu) -OH | | 122996-47-8 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
36 | Fmoc-Thi-OH | | 130309-35-2 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
37 | Fmoc-D-Tic-OH | | 130309-33-0 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
38 | Fmoc-Oic-OH | | 130309-37-4 | Icatibant | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
39 | Boc-Sar-OH | | 13734-36-6 | ସରାଲାସିନ୍ | | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
40 | Fmoc-Sar-OH | | 77128-70-2 | ସରାଲାସିନ୍ | | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
41 | Fmoc-Tyr (SO3Na) -OH.H2O | | 106864-37-3 | ସିନ୍କାଲାଇଡ୍ | | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
42 | Fmoc-D-Asp (OtBu) -OH | | 112883-39-3 | ଡାପ୍ଟୋମାଇସିନ୍ | | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
43 | Ac-Ser (tBu) -OH | | 77285-09-7 | Afamelanotide | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
44 | Boc-HomoCys (Trt) -OH | | 201419-16-1 | Depreotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
45 | Fmoc-HomoCys (Trt) -OH | | 167015-23-8 | Depreotide | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
46 | Fmoc-Dab-OH | | 161420-87-7 | ସାପ ବିଷ | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
* Max1 = ସର୍ବାଧିକ ଅଜ୍ଞାତ ଶୁଦ୍ଧତା |
ଅନ୍ୟ ସୂଚକ:
- ଏସିଟିକ୍ ଏସିଡ୍: ≤0.02% (ସମସ୍ତ ଉତ୍ପାଦ)
- ଇଥିଲ୍ ଆସେଟେଟ୍: ≤0.5% (ସମସ୍ତ ଉତ୍ପାଦ)
- ମଦ୍ୟପାନ: ≤0.5% (ସମସ୍ତ ଉତ୍ପାଦ)
- ସର୍ବାଧିକ ଅଜ୍ଞାତ ଅପରିଷ୍କାରତା: Fmoc-Trp (Boc) -OH (143824-78-6) ≤0.3%;ଅନ୍ୟମାନେ ≤0.2%